Format

Send to

Choose Destination
Int J Antimicrob Agents. 1999 Aug;12 Suppl 2:S17-22.

Fusidic acid in septicaemia and endocarditis.

Author information

1
Department of Infectious Diseases, Infection Control and Sexual Health, Princess Alexandra Hospital, Brisbane, Queensland, Australia. whitby@health.qld.gov.au

Abstract

The in vitro activity of fusidic acid against Staphylococcus aureus is confirmed in clinical studies which demonstrate that this antibiotic in combination with other agents, particularly beta-lactams, is efficacious in non-MRSA septicaemia. Some reports suggest that fusidic acid when used in combination, may significantly diminish the risk of relapse after cessation of therapy. However, in spite of over 30 years of use and its recommendation in a number of guidelines, published evidence is insufficient to allow reliable comment on the efficacy of the antibiotic in the treatment of endocarditis.

PMID:
10528783
DOI:
10.1016/s0924-8579(98)00070-3
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center